Humantakinogene hadenovec

N/A

Report date: 2025/06/27 20:00:57

Base Information

Drug NameHumantakinogene hadenovec
Drug Alias NameEnekinragene inzadenovecFX-201GQ-203PCRX-201
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector > Ad5 vector
Mechanisms of ActionInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsOsteoarthritis, KneeOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBaylor College Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesPacira Pharmaceuticals IncGeneQuine Biotherapeutics GmbH
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, KneeOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A